ALA-based photodynamic priming in murine skin increases blood flow and oxygenation

Aleksandra Ilina, Marien Ochoa, Xu Cao, Tayyaba Hasan, Brian W. PogueJournal of Biomedical Optics 2025 · DOI

TL;DR

This study investigates how fractionating light delivery in photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) impacts blood flow and oxygenation in mouse skin. They found that a small initial "priming" light dose, followed by a dark interval, significantly increases blood flow and tissue oxygenation, leading to potentially enhanced PDT efficacy.

What Problem Does This Paper Address?

Photodynamic therapy (PDT) is a promising treatment for various skin conditions, utilizing photosensitizing drugs and light to generate reactive oxygen species that kill cells. However, the complex dynamics within the tissue during PDT, such as changes in blood flow and oxygen availability, can significantly influence treatment efficacy. While fractionating light delivery has shown promise in improving PDT outcomes, the underlying biophysical mechanisms, particularly concerning blood flow and oxygenation, haven't been fully elucidated. This paper aims to bridge that gap by systematically examining how different light fractionation schemes affect these critical physiological parameters in the skin.

Methods

The researchers employed a multi-pronged approach using a murine skin model. They compared three light delivery schemes:

  1. Full light delivery: A single, 100 J/cm² dose.
  2. 50+50 scheme: Two equal 50 J/cm² doses separated by 2 hours.
  3. 5+95 scheme: A small 5 J/cm² "priming" dose, followed by a 2-hour dark interval, and then a 95 J/cm² main dose.

To assess the physiological changes, they utilized several non-invasive imaging techniques:

  • Quantitative fluorescence imaging: To measure protoporphyrin IX (PpIX) concentration, the active photosensitizer produced from ALA.
  • Tissue perfusion imager (MoorO2Flo-2): To quantify blood flow in the superficial skin layers.
  • Delayed fluorescence (DF) imaging: To assess tissue hypoxia, leveraging the property that PpIX's delayed fluorescence increases in the absence of oxygen.
  • Oxyphor phosphorescence lifetime quenching imaging: A more direct measurement of tissue oxygen partial pressure (pO2).

All measurements were taken on both the treated and contralateral control legs to allow for normalization and account for inter-animal variability.

Datasets

Not discussed in the paper. The study utilized a cohort of 15 athymic nude male mice.

Key Insights and Ideas

  • "Priming" effect of low-dose PDT: A small initial light dose (5% of the total) followed by a dark interval significantly enhances blood flow and tissue oxygenation, suggesting a "priming" effect that prepares the tissue for subsequent treatment.
  • Fractionation matters for blood flow: While a single full dose or a 50+50 split led to decreased blood flow (potentially due to vasoconstriction or vascular damage), the 5+95 scheme resulted in sustained vasodilation and increased blood flow.
  • PpIX replenishment is key: The 2-hour dark interval in the fractionated schemes allows for PpIX replenishment, ensuring sufficient photosensitizer is available for subsequent light delivery.
  • Hypoxia as a dynamic indicator: Delayed fluorescence from PpIX proved to be a sensitive indicator of tissue hypoxia, correlating with oxygen availability changes.
  • Synergistic effects: The combination of increased capillary flow and enhanced tissue oxygenation, alongside sufficient PpIX levels, likely contributes to the amplified PDT efficiency observed with the 5+95 scheme.

Key Results

  • The 5+95 fractionation scheme demonstrated a significant increase in blood flow and tissue oxygenation after the initial 5% light dose, which persisted throughout the treatment.
  • In contrast, the 50+50 and 100% full dose schemes showed a noticeable decrease in blood flow immediately after treatment, indicative of vasoconstriction or vascular damage.
  • Hypoxia measurements (via delayed fluorescence) showed a decrease (indicating increased oxygenation) in the 5+95 scheme, which was confirmed by direct pO2 measurements showing a significant rise after the initial 5% light dose.
  • PpIX concentration returned to near pretreatment levels during the 2-hour dark interval in the fractionated schemes, allowing for effective replenishment.

Limitations and Future Work

  • Animal model differences: The authors note that the animal model used (athymic nude mice) may have slight differences compared to models used in previous studies (e.g., SKH1 mice), which could influence results.
  • Generalizability: While promising, the findings are from a murine skin model and further validation in human studies is necessary.
  • Future Directions: The authors suggest that this "photodynamic optical priming" event, particularly the 5+95 scheme, could be a valuable neoadjuvant strategy to enhance radiotherapy or chemotherapy by improving oxygenation and drug delivery. Further research could explore optimizing the timing and dose of such priming protocols for various clinical applications.

Summary updated

Abstract

These observations suggest that increasing oxygen and capillary flow combined with increased PpIX production together yield increased PDT efficiency, amplified by this initial light dose from a photodynamic optical priming event occurring 2 h prior to full PDT light delivery.
BibTeX
@article{ilina2025ala,
  author = {Aleksandra Ilina and Marien Ochoa and Xu Cao and Tayyaba Hasan and Brian W. Pogue},
  title = {{ALA-based photodynamic priming in murine skin increases blood flow and oxygenation}},
  journal = {Journal of Biomedical Optics},
  year = {2025},
  doi = {10.1117/1.jbo.30.s3.s34106},
}
Figure